Production of human interferon-beta by Sendai virus and poly(rI).poly(rC): inhibition by neomycin

J Interferon Res. 1991 Dec;11(6):365-9. doi: 10.1089/jir.1991.11.365.

Abstract

Neomycin inhibits the production of interferon-beta (IFN-beta) in human fibroblast cells in response to Sendai virus or to poly(rI).poly(rC) in a concentration-dependent manner, and to the greatest extent effective when added prior to or up to 2 h after induction. This inhibitory effect is negated when the protein kinase C activator, SC-9, is present during IFN-beta production in response to poly(rI).poly(rC), but not in response to Sendai virus. These results suggest that in human cells both virus and poly(rI).poly(rC) utilize an early neomycin-sensitive signal transduction step for the production of IFN-beta; because neomycin binds specific phosphatidylinositol phosphates, both of these inducers very likely require hydrolysis of these phosphates.

MeSH terms

  • Cell Line
  • Cells, Cultured
  • Fibroblasts / drug effects
  • Fibroblasts / microbiology
  • Humans
  • Interferon-beta / antagonists & inhibitors*
  • Interferon-beta / biosynthesis
  • Neomycin / pharmacology*
  • Parainfluenza Virus 1, Human / drug effects*
  • Parainfluenza Virus 1, Human / growth & development
  • Poly I-C / pharmacology*
  • Signal Transduction
  • Sulfonamides / pharmacology

Substances

  • Sulfonamides
  • N-(6-phenylhexyl)-5-chloro-1-naphthalenesulfonamide
  • Interferon-beta
  • Neomycin
  • Poly I-C